Verastem Inc reports results for the quarter ended in March - Earnings Summary

Verastem

09/05/2024 21:59

* Verastem Inc  VSTM.OQ  reported a quarterly adjusted loss
of
$1.26​​ per share for the quarter ended in March, lower than the
same quarter last year, when the company reported EPS of -96
cents.  The mean expectation of seven analysts for the quarter
was for a loss of $1.03 per share. Wall Street expected
results to range from $-1.19 to -87 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Verastem Inc's reported EPS for the quarter was a loss of
$1.26​.
    * The company reported a quarterly loss of $33.86 million.
    * Verastem Inc shares had fallen by 3.4% this quarter and
gained 40.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 20.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Verastem Inc is
$32.00 
This summary was machine generated from LSEG data May 9 at 08:59
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -1.03          -1.26          Missed
 Dec. 31 2023      -0.62          -1.02          Missed
 Sep. 30 2023      -0.84          -0.75          Beat
 Jun. 30 2023      -1.06          -1.37          Missed